Tasimelteon
Top View
- Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’S Disease—Data from a Real World Cohort
- Belsomra: for the Treatment of Insomnia, Characterized by Difficulties with Sleep Onset And/Or Sleep Maintenance
- 5.01.552 Hetlioz® (Tasimelteon)
- Hetlioz, INN-Tasimelteon
- 8-11 January 2018 PRAC Meeting Minutes
- Medicaid List of Covered Drugs (Formulary)
- Effective in the Treatment of Jet Lag Disorder in an 8-Hour Phase Advance; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- BAP Guidelines-Sleep.Pdf
- Subject: Hetlioz (Tasimelteon) Original Effective Date: 4/26/2016
- Drug-Induced Diseases
- Specialty Pharmacy Program Drug List
- Hetlioz LQ™ (Tasimelteon Oral Suspension)
- NDT-4234-New Approaches in the Management of Insomnia
- Melatonin and Its Agonists: an Update Josephine Arendt and Shantha M
- Preferred Drug List (PDL)
- Federal Register/Vol. 80, No. 182/Monday, September 21, 2015
- Counseling Patients on Medication for Adult Psychiatric Disorders by Glen L
- Last Review Status/Date